Figure 3.
Biodistribution of 111In-basiliximab/DOTA at 144 hours in UPN-1 (left) and 18F-FDG-PET (right).

Biodistribution of 111In-basiliximab/DOTA at 144 hours in UPN-1 (left) and 18F-FDG-PET (right).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal